ago A, Wilmer C,
et al. Early and sustained dual oral antiplatelet therapy following
percutaneous coronary intervention: a randomized controlled trial.
JAMA 2002;288:2411-20.
142. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L,
Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel
alone after recent ischaemic stroke or transient ischaemic attack in
high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004;364:331-7.
143. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).
Lancet 1996;348:1329-39.
144. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al.
Clopidogrel and aspirin versus aspirin alone for the prevention of
atherothrombotic events. N Engl J Med 2006;354:1706-17.
145. Alberts MJ, Bergman DL, Molner E, Jovanovic BD, Ushiwata I,
Teruya J. Antiplatelet effect of aspirin in patients with with cerebrovascular disease. Stroke 2004;35:175-8.
146. Kasotakis G, Pipinos II, Lynch TG. Current evidence and clinical
implications of aspirin resistance. J Vasc Surg 2009;50:1500-10.
147. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al.
Cytochrome p-450 polymorphisms in response to clopidogrel. N Engl
J Med 2009;360:354-62.
148. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W,
Gottlieb S,